Literature DB >> 35813119

Peripheral modulation of chronic visceral pain.

Victor V Chaban1,2.   

Abstract

Chronic visceral pain is a complex and often a serious burden on patients' life. It is strongly implicated in the etiology of many diseases, which often are complicated by co-morbid depression and other psychiatric disorders, all of which pose significant health risks. Understanding the mechanisms of nociception is an important step in treating pain-associated chronic diseases. The inflammatory process that is often associated with nociception produces a number of mediators, which activate nociceptors by interacting with ligand-gated ion channels, activation of different signal transduction pathways or by sensitizing primary afferent neurons located within the dorsal root ganglia (DRG). Primary afferents studied in vitro or in vivo are well-accepted models to examine various nociceptive and anti-nociceptive signals in peripheral nervous system. This review focuses on the recent work in the area of peripheral modulation of chronic pain at the level of visceral primary afferent neurons. Many studies intended to develop a coherent framework for a better understanding of heterogeneity of nociceptive neurons functioning as a gate for pain transmission and novel therapeutic tool for pain relief. Specifically, recent studies from the author's research group helped to define the role of ATP-sensitive purinergic and vanilloid-sensitive TRPV1 receptors in DRG-mediated nociceptive pathways. Tropic and physiological changes associated with chronic visceral pain indeed are mediated through different pathways; therefore, designing new and specific anti-nociceptive therapies will have a major impact on quality of life in patients by significantly reducing pharmacological and therapeutic interventions.

Entities:  

Keywords:  functional diseases; nociception; sensory neurons

Year:  2020        PMID: 35813119      PMCID: PMC9268209     

Source DB:  PubMed          Journal:  Curr Trends Neurol        ISSN: 0972-8252


  10 in total

1.  Subclassified acutely dissociated cells of rat DRG: histochemistry and patterns of capsaicin-, proton-, and ATP-activated currents.

Authors:  J C Petruska; J Napaporn; R D Johnson; J G Gu; B Y Cooper
Journal:  J Neurophysiol       Date:  2000-11       Impact factor: 2.714

2.  A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders.

Authors:  Michael A Pezzone; Ruomei Liang; Matthew O Fraser
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

3.  Purine-mediated signalling in pain and visceral perception.

Authors:  G Burnstock
Journal:  Trends Pharmacol Sci       Date:  2001-04       Impact factor: 14.819

4.  Viscero-visceral hyperalgesia: characterization in different clinical models.

Authors:  Maria Adele Giamberardino; Raffaele Costantini; Giannapia Affaitati; Alessandra Fabrizio; Domenico Lapenna; Emmanuele Tafuri; Andrea Mezzetti
Journal:  Pain       Date:  2010-07-16       Impact factor: 6.961

5.  Multifactorial contributors to the severity of chronic pelvic pain in women.

Authors:  Ali Yosef; Catherine Allaire; Christina Williams; Abdel Ghaffar Ahmed; Tarek Al-Hussaini; Mohamad S Abdellah; Fontayne Wong; Sarka Lisonkova; Paul J Yong
Journal:  Am J Obstet Gynecol       Date:  2016-07-18       Impact factor: 8.661

Review 6.  Interdisciplinary chronic pain management: past, present, and future.

Authors:  Robert J Gatchel; Donald D McGeary; Cindy A McGeary; Ben Lippe
Journal:  Am Psychol       Date:  2014 Feb-Mar

Review 7.  Neural mechanisms of pelvic organ cross-sensitization.

Authors:  A P Malykhina
Journal:  Neuroscience       Date:  2007-09-08       Impact factor: 3.590

8.  Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis.

Authors:  Roja Rahimi; Shekoufeh Nikfar; Ali Rezaie; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

9.  Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome.

Authors:  L A Houghton; C Fell; P J Whorwell; I Jones; D P Sudworth; J D Gale
Journal:  Gut       Date:  2007-04-19       Impact factor: 23.059

Review 10.  Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article.

Authors:  Longtu Chen; Sheikh J Ilham; Bin Feng
Journal:  Anesth Pain Med       Date:  2017-01-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.